Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Tirzepatide is a prescription-only medication, and every legitimate online route ends in the same place: a licensed clinician evaluating you, writing a prescription, and a state-licensed pharmacy filling it. The molecule is a dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor agonist, and it reaches patients as Zepbound for chronic weight management, as Mounjaro for type 2 diabetes, or as a compounded preparation from a state-licensed pharmacy. Anything that skips the prescription step is not a shortcut — the FDA has repeatedly warned about products sold online that are counterfeit, mislabeled, or marketed as "not for human consumption."
What a Legitimate Online Intake Looks Like
A real telehealth evaluation collects your medical history, current medications, allergies, measured height and weight, relevant diagnoses and family history, and either an asynchronous clinician review or a live consultation. It also collects the information needed to screen for labeled contraindications.
The FDA’s own guidance is direct on this point: patients should obtain a prescription from their doctor and fill it at a state-licensed pharmacy. The agency lists telehealth red flags including any company that does not require screening and a prescription by a licensed clinician before providing medicine, or that has no licensed clinician available to answer questions afterwards.
Other red flags on the FDA’s list are worth memorising: claims that a compounded drug is the same as an FDA-approved drug, prices that seem too good to be true, packaging that arrives damaged or without instructions for use, and spelling errors or incorrect pharmacy addresses on the label.
Approved Product Versus Compounded Preparation
Zepbound and Mounjaro are FDA-approved finished products with reviewed labeling, established manufacturing controls and post-marketing surveillance obligations. A compounded tirzepatide preparation is none of those things. The FDA states that compounded drugs are not FDA approved and that it does not review them for safety, effectiveness or quality before marketing.
Compounded preparations are also not generics. Generic drugs must establish therapeutic equivalence to a reference listed drug, and no approved generic tirzepatide exists. Any description of a compounded preparation as a generic version of an approved brand is inaccurate.
What compounding legitimately is: preparation by a state-licensed pharmacy pursuant to a prescription for an individual patient, appropriate when that patient’s medical need cannot be met by an FDA-approved drug. PlexusDx works only with licensed 503A compounding pharmacies.
The Safety Signals the FDA Has Published
As of May 31, 2026 the FDA reported receiving more than 730 adverse event reports associated with compounded tirzepatide, alongside 990 for compounded semaglutide. The agency notes that state-licensed pharmacies which are not outsourcing facilities are not required by federal law to submit adverse event reports, so the true count is likely higher.
A recurring theme in those reports is dosing error — patients or clinicians miscalculating doses, and prescriptions written beyond what appears in the approved label. Some events were serious enough to require hospitalization.
The agency has also documented fraudulent compounded products whose labels name pharmacies that did not compound them or, in some cases, do not exist, and has established an import alert covering GLP-1 active pharmaceutical ingredients with potential quality concerns.
Products That Cannot Lawfully Be Compounded
Retatrutide and cagrilintide cannot be used in compounding under federal law. They are not components of FDA-approved drugs and have not been found safe and effective for any condition. The FDA has warned telehealth companies for marketing them, distributors for selling them to compounders, and outsourcing facilities for repackaging them.
Salt forms are a related problem specific to semaglutide: the agency states that semaglutide sodium and semaglutide acetate are different active ingredients from the one in the approved drugs, and it is not aware of any lawful basis for their use in compounding.
If an online seller offers any of these, that is not an innovative option. It is a signal to leave.
What to Verify Before You Pay
Confirm that a licensed clinician will evaluate you and that you can reach one afterwards. Confirm which pharmacy will dispense and that it is state-licensed. Confirm whether you are receiving an approved product or a compounded preparation, and expect a clear answer.
Ask how the medication ships. Injectable GLP-1 products require refrigeration as stated in their package inserts, and the FDA has received complaints about compounded GLP-1 drugs arriving warm or with inadequate ice packs. Its recommendation is not to use an injectable GLP-1 drug that arrives warm or insufficiently refrigerated.
Practical handling questions — how to store it, what to do about a missed dose, how to inject — belong to the pharmacy label and your prescriber. That is not evasiveness; it is that those answers are product-specific and patient-specific in ways a general article cannot safely cover.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
Can I get tirzepatide online without a prescription?
No. Tirzepatide is prescription-only in every form, and any seller offering it without a clinician evaluation is operating outside the law. The FDA has warned companies selling tirzepatide labeled "for research purposes" or "not for human consumption" directly to consumers with dosing instructions, and urges consumers not to purchase them because their quality is unknown and they may be harmful.
Is compounded tirzepatide the same as Zepbound or Mounjaro?
No. Zepbound and Mounjaro are FDA-approved finished products with reviewed labeling and established manufacturing controls. Compounded tirzepatide is not FDA-approved, and the agency does not review compounded drugs for safety, effectiveness or quality before marketing. It is also not a generic, because generics must establish therapeutic equivalence and no approved generic tirzepatide exists.
What are the warning signs of an unsafe online seller?
The FDA lists several: claiming a compounded drug is the same as an FDA-approved drug, deep discounts or prices that seem too good to be true, medicine that looks different from what you received before, damaged packaging or missing instructions for use, no screening or prescription by a licensed clinician, no clinician available afterwards, and spelling errors or wrong pharmacy addresses on the label.
What should I do if my medication arrives warm?
Do not use it, and contact the pharmacy. Injectable GLP-1 drugs require refrigeration as stated in their package inserts, and the FDA has received complaints of compounded GLP-1 products arriving warm or with inadequate ice packs. The agency specifically recommends that patients not use any injectable GLP-1 drug that arrives warm or with insufficient refrigeration.
Which tirzepatide product is approved for weight loss?
Zepbound is the tirzepatide product approved for chronic weight management in adults with obesity or overweight plus at least one weight-related condition, and separately for moderate to severe obstructive sleep apnea in adults with obesity. Mounjaro contains the same molecule but is approved only for glycemic control in type 2 diabetes. There is no FDA-approved oral tirzepatide.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Ozempic and Synthroid: Managing Thyroid Medication on Semaglutide
Navigating Semaglutide and Omeprazole: What You Need to Know